Researchers from the University of Missouri School of Medicine have discovered a specific combination immunotherapy that shows promise in the fight against liver cancer.
Imugene Limited (ASX:IMU), a clinical-stage immuno-oncology company, and City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient was dosed in a Phase 1 clinical trial evaluating the safety of novel cancer-killing virus CF33-hNIS VAXINIA when used in people with advanced solid tumors. The City of Hope-developed oncolytic virus has been shown to shrink colon, lung, breast, ovarian and pancreatic cancer tumors in preclinical laboratory and animal models.
Researchers at the University of East Anglia have found a link between bacteria and aggressive forms of prostate cancer.
Longstanding fears that using mobile phones may increase the risk of developing a brain tumour have been reignited recently by the launch of 5G (fifth generation) mobile wireless technologies. Mobile phones emit radiofrequency waves which, if absorbed by tissues, can cause heating and damage.
Note to journalists: Please report that this research will be presented at a meeting of the American Chemical Society.
Removing one type of T cell from donor blood used for stem cell grafts could greatly reduce a serious complication called graft-versus-host disease in patients with leukemia, according to a new study.